TEMPUS AI INC (TEM) Stock Price, Quote, News and Summary
NASDAQ:TEM - Nasdaq - US88023B1035 - Common Stock
TEM Quote and Key Statistics
TEMPUS AI INC
NASDAQ:TEM (1/21/2025, 8:00:02 PM)
After market: 53.91 +6.27 (+13.16%)47.64
+12.49 (+35.53%)
TEM Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -102.84% | ||
| ROE | -1859.89% | ||
| Debt/Equity | 8.17 |
TEM Performance and Technical Analysis
TEM Ownership and Analysts
TEM Latest News and Analysis
These stocks are moving in today's session
Which stocks are experiencing notable movement on Tuesday?
The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Why Tempus Ai Stock Is Skyrocketing Today
TempusAI Stock Surges On AI-Enabled Healthcare App Launch, Pelosi Buy: Retail Mood Stays Buoyant
TempusAI’s olivia includes features such as smart profile summary, AI-enabled notetaker, medical image sharing, health monitoring and direct data import.
Tempus AI Stock Is Trading Higher Tuesday: What's Going On?
Tempus AI Inc (NASDAQ:TEM) shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position in the technology company.
About TEM
Company Profile
Tempus AI Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Chicago, Illinois. The company went IPO on 2024-06-14. Tempus AI, Inc. is a technology company. The firm provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The firm's AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.
Company Info
TEMPUS AI INC
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 0
Company Website: https://www.tempus.com/
Phone: 18009765448
TEM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.74 | 219.20B | ||
| DHR | DANAHER CORP | 32.81 | 176.32B | ||
| A | AGILENT TECHNOLOGIES INC | 28.84 | 43.51B | ||
| IQV | IQVIA HOLDINGS INC | 18.94 | 37.33B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.72 | 27.95B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 50.99 | 24.96B | ||
| WAT | WATERS CORP | 36.33 | 24.57B | ||
| ILMN | ILLUMINA INC | 81.68 | 22.41B | ||
| ICLR | ICON PLC | 14.62 | 16.93B | ||
| RVTY | REVVITY INC | 26.21 | 15.08B | ||
| AVTR | AVANTOR INC | 22.21 | 14.82B | ||
| TECH | BIO-TECHNE CORP | 43.99 | 12.51B |